focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Yes looks like someone had a final set of figures to achieve, take that $96.5m Impairment Charge said primarily driven by a decrease in EnQuest's near term oil price assumptionsâŠoh really, with current Supply restrictions !
Just highlights the damming effect EPL has had on NS Operators given their Hedging programmes provide limited upside to higher OPâs.
Thankfully weâre heading towards 20% of output outside the Levy with the Cartel on our side, but this remains a long wait.
Good weâre moved on from Share ownership to guessing again. Thus mine is Cohort 7 advised within next two weeks with a continuing moribund share price. Remember Scientists are similar to Actuaries when it comes to caution !
Well it certainly looks like OPEC are now seeking Oil at US$90/bbl with latest support from Russia, the worldâs second largest oil exporter, having reportedly only yesterday said it intends to cut its oil exports, the size of which we await to see. Add to that Barclays have revised their Brent targets up for Q4â23 to $92 a barrel & for 2024 $97, so WTI wonât be far behind. It all helps !
Yes Murat Ticaret looks a great acquisition being highly cash generative and should add at least $180m annual revenue to top line with impressive EBITDA returns. Being involved with four of the five largest agricultural equipment manufacturers in the world, is a good start !
BV. If you recall MHRA clinical trial approval for AVA was early inâ21, to be greeted with much fanfare and words like âtransformationalâ from AS, so this was already attracting much focus and will have added to any valuation around that time. The point being this Market remains highly cynical of any clinical trial until proof of concept is delivered, and as an investor the market remains the final arbiter of valve on any given day, irrespective of how you, me or anyone else feels itâs currently undervalued. The SD, that gushed with impressive data, merely proved that point and whilst we hope this delivers within a reasonable time frame, Iâm not protective of the Company, nor does it take a commanding position in my portfolio.
First patient dosed in the AVA 6000 P1 Trial : 11th August 2021, Share Price then was 125p . Two years and numerous positive updates later, yet weâre 15% down. You can argue the science all day long but to date you canât argue the investment case. Tomorrow may be different, we hope so !
Well Iâm declaring this another âgood dayâ if your buyer. Whilst none of us know what the future holds, investing comes down to research and trusting in own judgement. Helps of course if you can just write off any investment without concern but equally can enjoy its success. Oh and Peak Oil demand is still years away !
Apre. these BBâs survive on discord and likely LSE will find your source of annoyance isnât binned by anyone, contrary to their outpourings. Indeed I enjoy reading the counter arguments for what they are, so probably best just âbite your lipâ otherwise you run the risk of seemingly being equally concerned of where the SP sits. Most investing here realise the risks and rewards involved hence probably donât bother engaging any longer. GL.
My earlier request went unanswered so did my own digging and now found the full T&Câs of that EPO. The EPO ( Order 1779) as reported in the ZG Gazette was awarded to Zulu Lithium ( Private ) Ltd. for 3 years expiring March â24 but that will require upgrading to a Full Mining Lease, if not done so already. If still outstanding that could now take some bargaining (!) but there is so much smoke surrounding this co., in particular the Financials, that Iâve seen enough to realise none of it will disappear when the monsoon season kicks in next month. Feel GR just lets you know the bare min. here so I wonât be investing. Seen enough !
Iâm curious, the Zulu Exclusive Prospecting Order expires March 2024. yet I canât find copy of its full T&Câs that were promised at the time. Given the political situation / cash constraints here, they may be relevant. Anyone seen a copy or know if an extension was agreed ?
@eazy. You ask âwhatâs our M.Cap ? ÂŁ30mâ . Well compared to many other Stocks itâs somewhat out of kilter !. Just take this BBâs most commented share - Premier African Minerals that sits with a near ÂŁ100m Cap , and is on life support. If anyone can convince me these two valuation shouldnât be reversed, Iâm all ears. Weâll get there though.